# Week 8

## 1. Checking S704L and L452 of Omicron and Delta   
![S704L Delta](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/S704L/S704L_Delta.png?raw=true)

![S704L BA.1](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/S704L/S704L_BA.1.png?raw=true)

![S704L BA.2](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/S704L/S704L_BA.2.png?raw=true)

![S704L BA.2.12](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/S704L/S704L_BA.2.12.png?raw=true)

![S704L BA.2.12.1](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/S704L/S704L_BA.2.12.1.png?raw=true)

![S704L BA.4](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/S704L/S704L_BA.4.png?raw=true)   
BA.4 does not have S704L mutation

![S704L BA.5](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/S704L/S704L_BA.5.png?raw=true)

## 2. Lineage:   
BA.2-->BA.5-->BA.5.2-->BF.7   
BA.2: 2021-10-22   
BA.5: 2022-01-10, South Africa, L452R F486B   
BA.5.2 2022-04-11: ORF9b: D16G
BF.7 2022-05-13 Belgium, R346T   

## 3. Mutations
Mutations on RBD are mostly concentrated in R346, R356, K444, L452, N460K, F486.   
BA.2.12 from India, BA.2.12.1 from Canada.   
Spike mutations L452Q and S704L are from antigenic drift, which are hard to accumulate. **But in only a month(Feb 2022), 2 mutations are accumulated.**   
S704L also shows convergency, that BA.1, BA.2, BA.5 all have **S704L change**. And BA.1 + S704L has growth advantage than BA.1
## 4. L452R
![L452R Delta](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/L452R/L452R_Delta.png?raw=true)

![L452R BA.1](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/L452R/L452R_BA1.png?raw=true)

![L452R BA.2](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/L452R/L452R_BA2.png?raw=true)

L452R BA.2.12 doesn't have.   

![L452R BA.2.12.1](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/L452R/L452R_BA2.12.1.png?raw=true)

![L452R BA.4](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/L452R/L452R_BA4.png?raw=true)

![L452R BA.5](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/L452R/L452R_BA5.png?raw=true)

## 5. BA.5.2.1
![P4715L BA.5.2.1](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/BA.5.2.1/P4715L.png?raw=true)

![P4715L BA.5](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/BA.5.2.1/P4715L_BA5.png?raw=true)

![P4715L Delta](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/BA.5.2.1/P4715L_Delta.png?raw=true)
### **P4715L** should be a very successful mutation, so as **D614G**, see below:   

![D614G BA.5.2.1](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/BA.5.2.1/D614G_BA.5.2.1.png?raw=true)

![D614G BA.5](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/BA.5.2.1/D614G_BA5.png?raw=true)

![D614G Delta](https://github.com/KirakiraZLY/Variants-and-mutation-rate-in-SARS-Cov2/blob/main/Img/Week8/BA.5.2.1/D614G_Delta.png?raw=true)

Through sequence analysis, in the spike protein S of the new coronavirus in the early stage of the outbreak, amino acid 614 was aspartic acid (D), but starting from March 2020, this amino acid was mutated to glycine (G). By June, the frequency of D614G had increased to 75%, and now, the D614G mutant has replaced the earlier virus as the dominant strain worldwide. Clinically, nasopharyngeal swabs from G614-infected individuals detected higher levels of viral RNA than D614-infected individuals, but did not alter the pathogenicity of the virus.   
通过序列分析，在疫情爆发早期新冠病毒的刺突蛋白S中，氨基酸614位为天冬氨酸（D），但从2020年3月份开始，该氨基酸突变为甘氨酸（G）。到6月份，D614G的频率已经增加到75%，现在，D614G突变体已经取代早期的病毒，成为世界范围内主要病毒株。在临床上，G614感染者的鼻咽拭子检测到的病毒RNA水平高于D614感染者，但是没有改变病毒的致病性。
https://zhuanlan.zhihu.com/p/350032710